Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Treasury Shares (2023 - 2024)

Historic Treasury Shares for Stoke Therapeutics (STOK) over the last 2 years, with Q4 2024 value amounting to $1.2 million.

  • Stoke Therapeutics' Treasury Shares fell 1917.67% to $1.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year decrease of 1917.67%. This contributed to the annual value of $1.2 million for FY2024, which is 1917.67% down from last year.
  • Per Stoke Therapeutics' latest filing, its Treasury Shares stood at $1.2 million for Q4 2024, which was down 1917.67% from $1.5 million recorded in Q4 2023.
  • In the past 5 years, Stoke Therapeutics' Treasury Shares ranged from a high of $1.5 million in Q4 2023 and a low of $1.2 million during Q4 2024